Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
83.28
Dollar change
+0.65
Percentage change
0.79
%
Index- P/E42.30 EPS (ttm)1.97 Insider Own1.62% Shs Outstand493.20M Perf Week-1.56%
Market Cap41.08B Forward P/E24.23 EPS next Y3.44 Insider Trans0.00% Shs Float485.31M Perf Month2.59%
Income974.00M PEG2.66 EPS next Q0.73 Inst Own52.60% Short Float0.92% Perf Quarter7.47%
Sales9.46B P/S4.35 EPS this Y9.59% Inst Trans- Short Ratio4.97 Perf Half Y8.32%
Book/sh41.82 P/B1.99 EPS next Y14.48% ROA3.31% Short Interest4.48M Perf Year21.91%
Cash/sh2.23 P/C37.31 EPS next 5Y15.91% ROE4.83% 52W Range67.14 - 88.23 Perf YTD6.61%
Dividend Est.0.28 (0.34%) P/FCF56.28 EPS past 5Y- ROI3.81% 52W High-5.61% Beta0.91
Dividend TTM0.24 (0.28%) Quick Ratio1.34 Sales past 5Y6.18% Gross Margin55.57% 52W Low24.05% ATR (14)1.11
Dividend Ex-DateMay 10, 2024 Current Ratio2.28 EPS Y/Y TTM189.69% Oper. Margin14.34% RSI (14)49.52 Volatility0.78% 1.19%
Employees25315 Debt/Eq0.25 Sales Y/Y TTM8.47% Profit Margin10.30% Recom1.84 Target Price93.93
Option/ShortYes / Yes LT Debt/Eq0.24 EPS Q/Q539.05% Payout32.25% Rel Volume0.92 Prev Close82.63
Sales Surprise-0.32% EPS Surprise3.64% Sales Q/Q8.34% EarningsFeb 27 AMC Avg Volume901.58K Price83.28
SMA20-2.54% SMA503.32% SMA2005.66% Trades Volume825,850 Change0.79%
Date Action Analyst Rating Change Price Target Change
Mar-14-24Initiated RBC Capital Mkts Sector Perform
Feb-06-24Resumed KeyBanc Capital Markets Overweight $87
Jan-23-24Initiated Bernstein Outperform $94.40
Dec-18-23Downgrade Redburn Atlantic Neutral → Sell
Dec-12-23Initiated Stifel Buy $85
Dec-04-23Downgrade Morgan Stanley Equal-Weight → Underweight $85 → $65
Aug-17-23Upgrade JP Morgan Neutral → Overweight $79.80 → $89.30
May-30-23Resumed Morgan Stanley Equal-Weight $85
May-10-23Upgrade Robert W. Baird Neutral → Outperform $75 → $90
Mar-01-23Upgrade Societe Generale Sell → Hold
Mar-14-24 11:37AM
Mar-13-24 08:34AM
Mar-12-24 04:30AM
Mar-08-24 02:53PM
07:31AM
09:55AM Loading…
Mar-06-24 09:55AM
Feb-29-24 04:19AM
Feb-28-24 03:39PM
05:53AM
Feb-27-24 07:00PM
04:30PM
10:40AM
06:46AM
Feb-22-24 09:15AM
Feb-05-24 01:16PM
09:02AM Loading…
Feb-01-24 09:02AM
Jan-10-24 05:22AM
Jan-09-24 04:30PM
Jan-05-24 08:00AM
Jan-04-24 09:44AM
Dec-27-23 09:01AM
Nov-15-23 12:31PM
Nov-14-23 04:30PM
Nov-08-23 09:03AM
Oct-30-23 09:41AM
09:01AM
Oct-11-23 10:04AM
09:40AM
Oct-10-23 08:01AM
Oct-02-23 09:35AM
01:01AM Loading…
Sep-09-23 01:01AM
Sep-06-23 04:30PM
Aug-17-23 09:39AM
Aug-16-23 02:08PM
Aug-15-23 04:30PM
Jul-17-23 07:43AM
Jul-11-23 06:42PM
May-22-23 04:51PM
01:01AM
May-19-23 11:16AM
May-16-23 06:40AM
May-15-23 08:08AM
May-10-23 12:34PM
May-09-23 04:43PM
04:34PM
May-06-23 03:00PM
May-05-23 04:30PM
May-01-23 10:44AM
Apr-14-23 07:08AM
06:53AM
Mar-29-23 05:59PM
04:58PM
Mar-23-23 09:05AM
Mar-20-23 08:55AM
Mar-12-23 11:44PM
Mar-03-23 10:19AM
Mar-01-23 09:03AM
Feb-28-23 07:08PM
Feb-27-23 04:30PM
Feb-12-23 09:05PM
Feb-06-23 07:38AM
Feb-02-23 12:27PM
Jan-23-23 12:58PM
12:43PM
Jan-13-23 06:54PM
Jan-05-23 01:05AM
Dec-28-22 10:05AM
Dec-16-22 04:04AM
Dec-02-22 12:14AM
Nov-29-22 08:30PM
Nov-24-22 02:26PM
Nov-23-22 10:24AM
08:24AM
Nov-22-22 01:01AM
Nov-16-22 11:04PM
11:01AM
Nov-15-22 04:30PM
Nov-02-22 09:27AM
Oct-31-22 05:45PM
Oct-26-22 01:46PM
Oct-05-22 09:25AM
Sep-29-22 09:02AM
Sep-13-22 12:01PM
Aug-29-22 12:08PM
Aug-26-22 09:03AM
Aug-23-22 04:33PM
03:49PM
03:26PM
02:05PM
11:42AM
09:17AM
06:16AM
Aug-22-22 09:37PM
09:20PM
Aug-11-22 09:53AM
Aug-09-22 04:30PM
Aug-01-22 11:26AM
Jul-26-22 12:49PM
12:46PM
Jul-25-22 12:18PM
Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the following segments: Surgical and Vision Care. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner on 1945 and is headquartered in Geneva, Switzerland.